MedTrace Logo

EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED)

NCT03852706 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2022-04-05

No results posted yet for this study

Summary

This study's primary objective is to perform a randomized controlled pilot study to assess the feasibility of using EEG-based neurofeedback to reduce the severity of treatment-resistant auditory verbal hallucinations ('hearing voices') in patients diagnosed with schizophrenia. Patients will be randomized to receive either EEG-based neurofeedback or treatment-as-usual.

Conditions

Interventions

OTHER

LORETA

Twenty sessions of neurofeedback training using LORETA in combination with z-scores.

OTHER

Treatment as usual

Treatment-as-usual

Sponsors & Collaborators

  • Actualise

    collaborator OTHER

  • University of Dublin, Trinity College

    lead OTHER

Principal Investigators

  • Simon McCarthy-Jones · University of Dublin, Trinity College

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-03-25
Completion
2022-03-25

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03852706 on ClinicalTrials.gov